These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 20136678)

  • 21. Common tinea infections in children.
    Andrews MD; Burns M
    Am Fam Physician; 2008 May; 77(10):1415-20. PubMed ID: 18533375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Fungal diseases of the skin (dermatomycoses). 1: Dermatomycoses of the feet].
    Meinhof W
    Fortschr Med; 1995 Jun; 113(16):253-6. PubMed ID: 7635378
    [No Abstract]   [Full Text] [Related]  

  • 23. [Terbinafine (Lamisil)].
    Breton MC
    Union Med Can; 1995 Nov; 124(3):20-5. PubMed ID: 8560634
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of tinea pedis with a single pulse of itraconazole.
    Bonifaz A; Saúl A
    Eur J Dermatol; 2002; 12(2):157-9. PubMed ID: 11872413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Usefulness and pharmacokinetic study of oral terbinafine for hyperkeratotic-type tinea pedis.
    Kikuchi I; Tanuma H; Morimoto K; Kawana S
    Mycoses; 2008 Nov; 51(6):523-31. PubMed ID: 18422915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel, single-dose, topical treatment of tinea pedis using terbinafine: results of a dose-finding clinical trial.
    de Chauvin MF; Viguié-Vallanet C; Kienzler JL; Larnier C
    Mycoses; 2008 Jan; 51(1):1-6. PubMed ID: 18076588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Step-wise treatment of athlete's foot (tinea pedis) using isoconazole combined with a corticosteroid followed by isoconazole alone.
    Olkhovskaya KB; Perlamutrov Y
    Mycoses; 2008 Sep; 51 Suppl 4():50-1. PubMed ID: 18783571
    [No Abstract]   [Full Text] [Related]  

  • 28. [Efficacy of the Myco-Polycid preparation in the form of tincture and cream for the treatment of dermatomycoses].
    Szymczykowa B
    Mykosen; 1975 Dec; 18(12):523-6. PubMed ID: 129703
    [No Abstract]   [Full Text] [Related]  

  • 29. A case of bullous tinea pedis with dermatophytid reaction caused by Trichophyton violaceum.
    Romano C; Rubegni P; Ghilardi A; Fimiani M
    Mycoses; 2006 May; 49(3):249-50. PubMed ID: 16681820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Observational evaluation of sertaconazole nitrate cream 2% in the treatment of pruritus related to tinea pedis.
    Kircik LH
    Cutis; 2009 Nov; 84(5):279-83. PubMed ID: 20099622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experimental and clinical investigation on oxiconazole.
    Wu SX; Shen YN; Yan N; Guo NR; Liu LL; Yang JQ
    Chin Med J (Engl); 1989 Aug; 102(8):644-6. PubMed ID: 2517622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Athlete's foot.
    Crawford F
    Clin Evid; 2004 Jun; (11):2128-32. PubMed ID: 15652103
    [No Abstract]   [Full Text] [Related]  

  • 33. Efficacy and safety of butenafine in superficial dermatophytoses (tinea pedis, tinea cruris, tinea corporis).
    Saple DG; Amar AK; Ravichandran G; Korde KM; Desai A
    J Indian Med Assoc; 2001 May; 99(5):274-5. PubMed ID: 11676116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatments of tinea pedis.
    Gupta AK; Chow M; Daniel CR; Aly R
    Dermatol Clin; 2003 Jul; 21(3):431-62. PubMed ID: 12956197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topical management of tinea pedis.
    Thomas B; Falk J; Allan GM
    Can Fam Physician; 2021 Jan; 67(1):30. PubMed ID: 33483393
    [No Abstract]   [Full Text] [Related]  

  • 36. Viability of pathogenic dermatophytes during a 4-week treatment with 1% topical luliconazole for tinea pedis.
    Iwanaga T; Ushigami T; Anzawa K; Mochizuki T
    Med Mycol; 2020 Apr; 58(3):401-403. PubMed ID: 31111903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inflammatory tinea pedis with bacterial superinfection effectively treated with isoconazole nitrate and diflucortolone valerate combination therapy.
    Friedrich M
    Mycoses; 2013 May; 56 Suppl 1():23-5. PubMed ID: 23574021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Introduction to Advances in Tinea Pedis Management.
    Kircik LH
    J Drugs Dermatol; 2016 Feb; 15(2 Suppl):s43. PubMed ID: 26885797
    [No Abstract]   [Full Text] [Related]  

  • 39. Adherence to oral and topical medication in 445 patients with tinea pedis as assessed by the Morisky Medication Adherence Scale-8.
    Tsunemi Y; Abe S; Kobayashi M; Kitami Y; Onozuka D; Hagihara A; Takeuchi S; Murota H; Sugaya M; Masuda K; Hiragun T; Kaneko S; Saeki H; Shintani Y; Tanioka M; Imafuku S; Abe M; Inomata N; Morisky DE; Furue M; Katoh N
    Eur J Dermatol; 2015; 25(6):570-7. PubMed ID: 26574949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapy of tinea pedis. Theoretical and experimental data].
    Moretti G; Bertamino R; Crovato F
    Minerva Dermatol; 1967 Jul; 42(7):320-7. PubMed ID: 5608968
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.